Quest Diagnostics (DGX) Revenue (2009 - 2026)

Quest Diagnostics has reported Revenue for 18 years, with the latest figure at $3.0 billion in Q2 2026.

• Quarterly Revenue rose 10.21% year-over-year to $3.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.6 billion (up 9.87% YoY) and the FY2025 annual result came in at $11.0 billion, up 11.78% from the prior year.
• Revenue advanced to $3.0 billion in Q2 2026 per DGX's latest filing, from $2.9 billion in the prior quarter.
• Over five years, Revenue peaked at $3.0 billion in Q2 2026 and troughed at $2.3 billion in Q4 2023.
• A 5-year average of $2.6 billion and a median of $2.5 billion in 2022 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue slipped 14.98% in 2022, then grew 15.19% in 2025.
• Over 5 years, Revenue stood at $2.3 billion in 2022, then fell by 1.93% to $2.3 billion in 2023, then gained by 14.55% to $2.6 billion in 2024, then advanced by 7.06% to $2.8 billion in 2025, then rose by 8.45% to $3.0 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $3.0 billion, $2.9 billion, and $2.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.